Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nxera Pharma logo — Nxera Pharma is a technology powered biopharma company.

Nxera Pharma

Nxera Pharma is a technology powered biopharma company.

Founded 1990 Japan Japan 254 employees

General Information

Company Name Nxera Pharma
Founded Year 1990
Location Japan Japan +3
Employees 254
Social

Get notified when Nxera Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nxera Pharma

Nxera Pharma is a technology-powered biopharma company dedicated to improving the lives of patients with unmet needs in Japan and globally. With a history dating back to 1990, the company has established itself as a prominent player in the industry. Nxera Pharma is actively involved in commercializing several products in Japan and is simultaneously pursuing an extensive pipeline of over 30 active programs from discovery through to late clinical stage, both internally and in partnership with leading pharma and biotech companies. The company's focus areas encompass neurology, GI and immunology, metabolic disorders, and rare diseases, leveraging its unique and industry-leading GPCR-targeted structure-based drug discovery "NxWave" platform to provide a sustainable source of best- or first-in-class candidates. Nxera Pharma boasts a team of over 350 talented individuals located at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland), and Seoul (South Korea). As a testament to its growth and success, Nxera Pharma is listed on the Tokyo Stock Exchange (ticker: 4565). With a focus on cutting-edge technology and addressing critical medical needs, Nxera Pharma presents an exciting opportunity for venture capital investors aiming to make a significant impact in the biopharma sector.

Taxonomy: Biopharma, Technology, Pipeline, Drug Discovery, Neurology, Immunology, Gastroenterology, GPCR-targeted, Rare Diseases, Metabolic Disorders, Pre-Clinical, Molecular Pharmacology, Computational Chemistry, Structure-Based Drug Design, Innovative Medicines

No funding data available for Nxera Pharma yet.

Get notified when Nxera Pharma raises funding

Nxera Pharma Alternatives & Competitors

Nxera Pharma vs
Nxera Pharma
Nxera Pharma Japan

Nxera Pharma is a technology-powered biopharma company.

277 employees
Nxera Pharma vs
Sumitomo Pharma Oncology
Sumitomo Pharma Oncology United States

is part of Sumitomo Pharma America as of July 2023

49 employees
Health Care, Health and Wellness
Nxera Pharma vs
Chugai Pharma USA, Inc.
Chugai Pharma USA, Inc.

INNOVATION BEYOND IMAGINATION

IPO
232 employees

FAQ About Nxera Pharma

Nxera Pharma is a technology powered biopharma company.
Nxera Pharma was founded in 1990.
Nxera Pharma is headquartered in Japan.
Nxera Pharma has approximately 254 employees.
Top alternatives and competitors to Nxera Pharma include Nxera Pharma, Sumitomo Pharma Oncology, Chugai Pharma USA, Inc., Initiator Pharma , PostEra. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nxera Pharma and Nxera Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nxera Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy